Age (yrs) |
Gender |
HTN |
DM |
Pre-op Cr (mg/dL) |
Post-Op Cr (mg/dL) |
STS
Score (%) |
EF (%) |
30 Day
Mortality |
41 |
Female |
No |
Yes |
1.06 |
1.99 |
1.3 |
16 |
No |
42 |
Female |
Yes |
Yes |
1.74 |
2.37 |
2.6 |
47 |
No |
43 |
Male |
Yes |
Yes |
4.72 |
6.33 |
3.1 |
46 |
No |
52 |
Male |
Yes |
Yes |
6.15 |
8.73 |
3.13 |
43 |
No |
53 |
Female |
Yes |
Yes |
1.18 |
2.29 |
1.02 |
63 |
No |
59 |
Male |
Yes |
Yes |
3.16 |
3.91 |
2.21 |
62 |
No |
65 |
Female |
Yes |
Yes |
0.73 |
1.71 |
4.23 |
27 |
No |
68 |
Male |
Yes |
Yes |
2.25 |
1.63 |
1.69 |
65 |
No |
68 |
Male |
Yes |
No |
1.98 |
3.81 |
1.35 |
49 |
No |
70 |
Male |
Yes |
No |
1.3 |
1.65 |
1.86 |
25 |
No |
72 |
Female |
Yes |
No |
0.9 |
1.21 |
2.82 |
60 |
No |
75 |
Male |
Yes |
Yes |
1.08 |
4.71 |
0.56 |
52 |
No |
77 |
Male |
Yes |
Yes |
2.83 |
5.45 |
6.8 |
33 |
No |
78 |
Male |
Yes |
Yes |
1.21 |
3.52 |
50 |
9 |
No |
83 |
Male |
No |
Yes |
1.8 |
1.79 |
5.7 |
5 |
No |
84 |
Male |
Yes |
No |
1 |
1.6 |
3.25 |
65 |
No |
89 |
Male |
Yes |
Yes |
1.37 |
2.28 |
5.41 |
30 |
No |